Daewoong (003090) - Total Liabilities
Based on the latest financial reports, Daewoong (003090) has total liabilities worth ₩1.47 Trillion KRW (≈ $994.79 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 003090 cash generation efficiency to assess how effectively this company generates cash.
Daewoong - Total Liabilities Trend (2000–2024)
This chart illustrates how Daewoong's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Daewoong to evaluate the company's liquid asset resilience ratio.
Daewoong Competitors by Total Liabilities
The table below lists competitors of Daewoong ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
S.J.S. Enterprises Limited
NSE:SJS
|
India | Rs2.31 Billion |
|
RaySearch Laboratories AB (publ)
ST:RAY-B
|
Sweden | Skr1.02 Billion |
|
Zhongrui Co Ltd
SHE:301587
|
China | CN¥330.25 Million |
|
Shanghai Metersbonwe Fashion&Accessories Co Ltd
SHE:002269
|
China | CN¥1.67 Billion |
|
Anhui Zhonghuan Environmental Protection Technology Co Ltd
SHE:300692
|
China | CN¥4.24 Billion |
|
Guangbo Group Stock Co Ltd
SHE:002103
|
China | CN¥995.15 Million |
|
Hindustan Construction Company Limited
NSE:HCC
|
India | Rs74.45 Billion |
|
AMN Healthcare Services Inc
NYSE:AMN
|
USA | $1.49 Billion |
Liability Composition Analysis (2000–2024)
This chart breaks down Daewoong's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Daewoong market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Daewoong's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Daewoong (2000–2024)
The table below shows the annual total liabilities of Daewoong from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩1.22 Trillion ≈ $825.56 Million |
+32.06% |
| 2023-12-31 | ₩922.48 Billion ≈ $625.15 Million |
+4.90% |
| 2022-12-31 | ₩879.41 Billion ≈ $595.96 Million |
+13.23% |
| 2021-12-31 | ₩776.67 Billion ≈ $526.34 Million |
+7.78% |
| 2020-12-31 | ₩720.61 Billion ≈ $488.35 Million |
+12.26% |
| 2019-12-31 | ₩641.93 Billion ≈ $435.02 Million |
+2.24% |
| 2018-12-31 | ₩627.86 Billion ≈ $425.49 Million |
+2.95% |
| 2017-12-31 | ₩609.85 Billion ≈ $413.28 Million |
+1.19% |
| 2016-12-31 | ₩602.65 Billion ≈ $408.41 Million |
+45.63% |
| 2015-12-31 | ₩413.82 Billion ≈ $280.44 Million |
+37.03% |
| 2014-12-31 | ₩302.00 Billion ≈ $204.66 Million |
+42.86% |
| 2013-12-31 | ₩211.40 Billion ≈ $143.26 Million |
+79.42% |
| 2012-12-31 | ₩117.83 Billion ≈ $79.85 Million |
-16.35% |
| 2011-12-31 | ₩140.85 Billion ≈ $95.45 Million |
-50.65% |
| 2010-12-31 | ₩285.42 Billion ≈ $193.43 Million |
+3.02% |
| 2009-12-31 | ₩277.06 Billion ≈ $187.76 Million |
+2.14% |
| 2008-12-31 | ₩271.26 Billion ≈ $183.83 Million |
+53.71% |
| 2007-12-31 | ₩176.48 Billion ≈ $119.60 Million |
+11.49% |
| 2006-12-31 | ₩158.29 Billion ≈ $107.27 Million |
+16.46% |
| 2005-12-31 | ₩135.92 Billion ≈ $92.11 Million |
+16.63% |
| 2004-12-31 | ₩116.54 Billion ≈ $78.98 Million |
+11.64% |
| 2003-12-31 | ₩104.39 Billion ≈ $70.74 Million |
-7.38% |
| 2002-12-31 | ₩112.71 Billion ≈ $76.38 Million |
-1.67% |
| 2001-12-31 | ₩114.63 Billion ≈ $77.68 Million |
-20.15% |
| 2000-12-31 | ₩143.55 Billion ≈ $97.28 Million |
-- |
About Daewoong
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Phar… Read more